Airflow Perturbation Device (APD) for the Evaluation of Pulmonary and Sleep Disorders
NCT ID: NCT03054116
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
199 participants
OBSERVATIONAL
2013-04-01
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation
NCT05459116
A Comparison of Optimal PEEP Determination Guided by EIT and G5 Device in Moderate and Severe ARDS Patients
NCT03112512
Clinical Application of Electrical Impedance Tomography for Individual Adjustment of Ventilator Settings
NCT02703012
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
NCT00494117
Auditory Evoked Potential Monitoring on Bronchoscopy
NCT01448811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Airflow pertubation device
Participants have airway resistance measured at the mouth by tidal breathing into a mouth-piece connected to the airflow perturbation device.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred for PFTs and/or PSG at WRNMMC
* All races and ethnicities will be included
* Pregnant women will be included
Exclusion Criteria
* If mental status is questionable, the patient will be excluded at the discretion of the consenting provider
* Unable/unwilling to follow the directions necessary for APD use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Walter Reed National Military Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aaron B. Holley
Aaron Holley, MD, Chief of Sleep Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
383145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.